Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dormicum
2. Hydrochloride, Midazolam
3. Maleate, Midazolam
4. Midazolam
5. Midazolam Maleate
6. Ro 21 3981
7. Ro 21-3981
8. Ro 213981
9. Versed
1. Midazolam Hcl
2. 59467-96-8
3. Versed
4. Hypnovel
5. Midazolam Hydrochloride [usan]
6. Ro 21-3981/003
7. Buccolam
8. Midazolam Hydrochloride Civ
9. Nsc-751451
10. W7ttw573jj
11. Shp615
12. Shp-615
13. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine Hydrochloride
14. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
15. Rocam
16. Ro-213981001
17. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine Hydrochloride
18. Dsstox_cid_27824
19. Dsstox_rid_82587
20. Dsstox_gsid_47846
21. Midazolam Hydrochloride (usan)
22. Cas-59467-96-8
23. Ncgc00168254-01
24. Einecs 261-776-6
25. Unii-w7ttw573jj
26. Ro-21-3981/003
27. Versed Hydrochloride
28. Versed (tn)
29. Seizalam
30. Hypnovel Hydrochloride
31. Midazolam Hydrochloride Preservative Free
32. Midazolam (hydrochloride)
33. Schembl41265
34. Mls001401415
35. Chebi:6932
36. Chembl1200420
37. Dtxsid8047846
38. Hy-b0676a
39. Bcp15579
40. Midazolam Hydrochloride [mi]
41. Tox21_112613
42. Nsc751451
43. Midazolam Hydrochloride [hsdb]
44. Akos024457308
45. Tox21_112613_1
46. Ccg-100983
47. Midazolam Hydrochloride [mart.]
48. Midazolam Hydrochloride [vandf]
49. Nc00233
50. Nsc 751451
51. 4h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Hydrochloride
52. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine Monohydrochloride
53. 8-chloro-6-(o-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine Monohydrochloride
54. Midazolam Hydrochloride [who-dd]
55. Ncgc00168254-02
56. 4h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Monohydrochloride
57. Smr000469160
58. Midazolam Hydrochloride [orange Book]
59. Midazolam Hydrochloride Civ [usp-rs]
60. D00696
61. 467m968
62. Q27292444
63. 4h-imidazo[1,5a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Hydrochloride
Molecular Weight | 362.2 g/mol |
---|---|
Molecular Formula | C18H14Cl2FN3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 361.0548810 g/mol |
Monoisotopic Mass | 361.0548810 g/mol |
Topological Polar Surface Area | 30.2 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 471 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride |
Drug Label | Midazolam hydrochloride is a water-soluble benzodiazepine available as a sterile, nonpyrogenic parenteral dosage form for intravenous or intramuscular injection. Each mL contains midazolam hydrochloride equivalent to 1 mg or 5 mg midazolam USP compou... |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Syrup; Injectable |
Route | Injection; Oral |
Strength | eq 2mg base/ml; eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Ranbaxy; Bedford; Hospira; Gland Pharma; Roxane; Hi Tech Pharma; Paddock; Fresenius Kabi Usa; Hikma Maple; Bedford Labs; Akorn |
2 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride preservative free |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Sagent Strides; Hospira; Bd Rx |
3 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride |
Drug Label | Midazolam hydrochloride is a water-soluble benzodiazepine available as a sterile, nonpyrogenic parenteral dosage form for intravenous or intramuscular injection. Each mL contains midazolam hydrochloride equivalent to 1 mg or 5 mg midazolam USP compou... |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Syrup; Injectable |
Route | Injection; Oral |
Strength | eq 2mg base/ml; eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Ranbaxy; Bedford; Hospira; Gland Pharma; Roxane; Hi Tech Pharma; Paddock; Fresenius Kabi Usa; Hikma Maple; Bedford Labs; Akorn |
4 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride preservative free |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Sagent Strides; Hospira; Bd Rx |
Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from three months to less than 18 years).
Buccolam must only be used by parents / carers where the patient has been diagnosed to have epilepsy.
For infants between three and six months of age, treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
Epileptic seizures
Adjuvants, Anesthesia
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)
Anesthetics, Intravenous
Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N05CD08
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39991
Submission : 2024-06-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-29
Pay. Date : 2018-02-20
DMF Number : 25204
Submission : 2011-08-01
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm : R. S. No. 50/1, Mukteswarapuram (V), Jaggalahpet (M), Krishna -District- 521175,...
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm : Plot No. 75/76, Chikhloli, MIDC, Ambernath (W), Dist- Thane
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0101
Address of the Firm : 21-M Attibele Industrial Area, Anekal Taluk, Bangalore-562107
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-134
Start Marketing Date : 2020-11-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (20mg/20mg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-1050
Start Marketing Date : 2024-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12828-0092
Start Marketing Date : 2021-10-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0103
Start Marketing Date : 2012-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
About the Company : Since its inception in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. With a strong focus on customer support, Seqens assists ...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Su...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of...
About the Company : Lake Chemicals is specialized in Benzodiazepine and CNS range of products such as Alprazolam, Bromazepam, Clobazam, Clonazepam, Midazolam Salts, Lorazepam, Olanzapine Form-1 etc. H...
About the Company : Nortec Química stands as the largest manufacturer of Active Pharmaceutical Ingredients (IFAs) in Latin America, embarking on its mission to ensure the availability of quality medi...
About the Company : Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a s...
About the Company : Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a s...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
67
PharmaCompass offers a list of Midazolam Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Midazolam Hydrochloride manufacturer or Midazolam Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Midazolam Hydrochloride manufacturer or Midazolam Hydrochloride supplier.
PharmaCompass also assists you with knowing the Midazolam Hydrochloride API Price utilized in the formulation of products. Midazolam Hydrochloride API Price is not always fixed or binding as the Midazolam Hydrochloride Price is obtained through a variety of data sources. The Midazolam Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Midazolam Hcl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Midazolam Hcl, including repackagers and relabelers. The FDA regulates Midazolam Hcl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Midazolam Hcl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Midazolam Hcl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Midazolam Hcl supplier is an individual or a company that provides Midazolam Hcl active pharmaceutical ingredient (API) or Midazolam Hcl finished formulations upon request. The Midazolam Hcl suppliers may include Midazolam Hcl API manufacturers, exporters, distributors and traders.
click here to find a list of Midazolam Hcl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Midazolam Hcl DMF (Drug Master File) is a document detailing the whole manufacturing process of Midazolam Hcl active pharmaceutical ingredient (API) in detail. Different forms of Midazolam Hcl DMFs exist exist since differing nations have different regulations, such as Midazolam Hcl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Midazolam Hcl DMF submitted to regulatory agencies in the US is known as a USDMF. Midazolam Hcl USDMF includes data on Midazolam Hcl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Midazolam Hcl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Midazolam Hcl suppliers with USDMF on PharmaCompass.
A Midazolam Hcl written confirmation (Midazolam Hcl WC) is an official document issued by a regulatory agency to a Midazolam Hcl manufacturer, verifying that the manufacturing facility of a Midazolam Hcl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Midazolam Hcl APIs or Midazolam Hcl finished pharmaceutical products to another nation, regulatory agencies frequently require a Midazolam Hcl WC (written confirmation) as part of the regulatory process.
click here to find a list of Midazolam Hcl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Midazolam Hcl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Midazolam Hcl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Midazolam Hcl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Midazolam Hcl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Midazolam Hcl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Midazolam Hcl suppliers with NDC on PharmaCompass.
Midazolam Hcl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Midazolam Hcl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Midazolam Hcl GMP manufacturer or Midazolam Hcl GMP API supplier for your needs.
A Midazolam Hcl CoA (Certificate of Analysis) is a formal document that attests to Midazolam Hcl's compliance with Midazolam Hcl specifications and serves as a tool for batch-level quality control.
Midazolam Hcl CoA mostly includes findings from lab analyses of a specific batch. For each Midazolam Hcl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Midazolam Hcl may be tested according to a variety of international standards, such as European Pharmacopoeia (Midazolam Hcl EP), Midazolam Hcl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Midazolam Hcl USP).